PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Eichhorst, Barbara
TI  - MRD and Clinical Response Predictors of PFS in CLL
DP  - 2014  01
TA  - MD Conference Express
PG  - 17--18
VI  - 14
IP  - 55
4099  - http://mdc.sagepub.com/content/14/55/17.short
4100  - http://mdc.sagepub.com/content/14/55/17.full
AB  - In chronic lymphocytic leukemia, progression-free survival in minimal residual disease–negative patients can be best predicted using a combination of minimal residual disease and the clinical response. The combination is more accurate than clinical response alone. Assessment using only splenomegaly has no influence on progression-free survival prediction.